Distinct Features of Gut Microbiota in High-Altitude Tibetan and Middle-Altitude Han Hypertensive Patients
From BugSigDB
Jump to:navigation, search
Study information
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
study design
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
URI
Authors
Zhu LL, Ma ZJ, Ren M, Wei YM, Liao YH, Shen YL, Fan SM, Li L, Wu QX, Gao ZS, Song JF, Ma YL
Journal
Cardiology research and practice
Year
2020
Indigenous animals show unique gut microbiota (GM) in the Tibetan plateau. However, it is unknown whether the hypertensive indigenous people in plateau also have the distinct gut bacteria, different from those living in plains. We sequenced the V3-V4 region of the gut bacteria 16S ribosomal RNA (rRNA) gene of feces samples among hypertensive patients (HPs) and healthy individuals (HIs) from 3 distinct altitudes: Tibetans from high altitude (3600-4500 m, n = 38 and 34), Hans from middle altitude (2260 m, n = 49 and 35), and Hans from low altitude (13 m, n = 34 and 35) and then analyzed the GM composition among hypertensive and healthy subgroups using the bioinformatics analysis, respectively. The GM of high-altitude Tibetan and middle-altitude Han HPs presented greater α- and β-diversities, lower ratio of Firmicutes/Bacteroidetes (F/B), and higher abundance of beneficial Verrucomicrobia and Akkermansia than the low-altitudes HPs did. The GM of high-altitude Tibetan and middle-altitude HIs showed greater α-diversity and lower ratio of F/B than the low-altitudes HIs did. But, β-diversity and abundance of Verrucomicrobia and Akkermansia among different subgroups of HIs did not show any differences. Conclusively, the high-altitude Tibetan and middle-altitude Han HPs have a distinct feature of GM, which may be important in their adaptation to hypertension in the plateau environments.
Experiment 1
Reviewed Marked as Reviewed by Fatima on 2021/07/28
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Hypertension (hypertensive disease) or (hypertension),[X]Hypertensive diseases,[X]Hypertensive diseases (disorder),Blood Pressure, High,blood pressure, high,blood pressure, increased,Blood Pressures, High,High Blood Pressure,high blood pressure,High blood pressure (& [essential hypertension]),High Blood Pressures,HTN,HTN - hypertension,hyperpiesia,hypertension,hypertension NOS,HYPERTENSIVE DISEASE,hypertensive disease,Hypertensive disease (disorder),hypertensive disease NOS,Hypertensive disease NOS (disorder),hypertensive disorder,increased blood pressure,pressure, high blood,SURG COMP - HYPERTENSION,vascular hypertensive disorder,Hypertension
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Han Hypertensive at Low Altitude (LHH)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Tibetan Hypertensive at High Altitude (HTH)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Tibetan participants with hypertension living at high altitudes.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 34
- Group 1 sample size Number of subjects in the case (exposed) group
- 38
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- 3 months
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Statistical test
- T-Test
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
- Matched on Factors on which subjects have been matched on in a case-control study
- age, sex
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
Signature 1
Reviewed Marked as Reviewed by Lwaldron on 2021/02/18
Source: Figure 2c
Description:
Abundance in Group 1: decreased abundance in Tibetan Hypertensive at High Altitude (HTH)
| NCBI | Quality Control | Links |
|---|---|---|
| Bacillota |
Revision editor(s): Manuela
Signature 2
Reviewed Marked as Reviewed by Lwaldron on 2021/02/18
Source: Figure 2c
Description:
Abundance in Group 1: increased abundance in Tibetan Hypertensive at High Altitude (HTH)
| NCBI | Quality Control | Links |
|---|---|---|
| Bacteroidota | ||
| Verrucomicrobiota |
Revision editor(s): Manuela
Experiment 2
Reviewed Marked as Reviewed by Fatima on 2021/07/16
Differences from previous experiment shown
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Han Hypertensive at Middle Altitude (MHH)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 49
Lab analysis
Statistical Analysis
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Not specified
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
Signature 1
Reviewed Marked as Reviewed by Lwaldron on 2021/02/18
Source: Figure 2g
Description:
Abundance in Group 1: decreased abundance in Tibetan Hypertensive at High Altitude (HTH)
| NCBI | Quality Control | Links |
|---|---|---|
| Candidatus Saccharibacteria | ||
| Pseudomonadota |
Revision editor(s): Manuela
Signature 2
Reviewed Marked as Reviewed by Lwaldron on 2021/02/18
Source: Figure 2g
Description:
Abundance in Group 1: increased abundance in Tibetan Hypertensive at High Altitude (HTH)
| NCBI | Quality Control | Links |
|---|---|---|
| Bacteroidota |
Revision editor(s): Manuela
Experiment 3
Reviewed Marked as Reviewed by Fatima on 2021/07/16
Differences from previous experiment shown
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Han Healthy at Low Altitude (LHN)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Tibetan Healthy at High Altitude (HTN)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Tibetan healthy participants living at high altitudes.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 35
- Group 1 sample size Number of subjects in the case (exposed) group
- 34
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
Signature 1
Reviewed Marked as Reviewed by Lwaldron on 2021/02/18
Source: Figure 2d
Description:
Abundance in Group 1: decreased abundance in Tibetan Healthy at High Altitude (HTN)
| NCBI | Quality Control | Links |
|---|---|---|
| Candidatus Saccharibacteria | ||
| Fusobacteriota | ||
| Pseudomonadota |
Revision editor(s): Manuela
Signature 2
Reviewed Marked as Reviewed by Lwaldron on 2021/02/18
Source: Figure 2d
Description:
Abundance in Group 1: increased abundance in Tibetan Healthy at High Altitude (HTN)
| NCBI | Quality Control | Links |
|---|---|---|
| Bacteroidota |
Revision editor(s): Manuela
Experiment 4
Reviewed Marked as Reviewed by Fatima on 2021/07/16
Differences from previous experiment shown
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Han Healthy at Middle Altitude (MHN)
Lab analysis
Statistical Analysis
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
Signature 1
Reviewed Marked as Reviewed by Lwaldron on 2021/02/18
Source: Figure 2h
Description:
Abundance in Group 1: decreased abundance in Tibetan Healthy at High Altitude (HTN)
| NCBI | Quality Control | Links |
|---|---|---|
| Candidatus Saccharibacteria |
Revision editor(s): Manuela
Experiment 5
Reviewed Marked as Reviewed by Fatima on 2021/10/14
Differences from previous experiment shown
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Han Hypertensive at Low Altitude (LHH)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Han Hypertensive at Middle Altitude (MHH)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Han hypertensive participants living at middle altitude.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 34
- Group 1 sample size Number of subjects in the case (exposed) group
- 49
Lab analysis
Statistical Analysis
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Not specified
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
Signature 1
Reviewed Marked as Reviewed by Lwaldron on 2021/02/18
Source: Figure 2e
Description:
Abundance in Group 1: decreased abundance in Han Hypertensive at Middle Altitude (MHH)
| NCBI | Quality Control | Links |
|---|---|---|
| Bacillota |
Revision editor(s): Manuela
Signature 2
Reviewed Marked as Reviewed by Lwaldron on 2021/02/18
Source: Figure 2e
Description:
Abundance in Group 1: increased abundance in Han Hypertensive at Middle Altitude (MHH)
| NCBI | Quality Control | Links |
|---|---|---|
| Acidobacteriota | ||
| Bacteroidota | ||
| Candidatus Saccharibacteria | ||
| Mycoplasmatota | ||
| Verrucomicrobiota |
Revision editor(s): Manuela
Experiment 6
Reviewed Marked as Reviewed by Fatima on 2021/10/14
Differences from previous experiment shown
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Han Healthy at Low Altitude (LHN)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Han Healthy at Middle Altitude (MHN)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Han healthy participants living at middle altitude.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 35
- Group 1 sample size Number of subjects in the case (exposed) group
- 35
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
Signature 1
Reviewed Marked as Reviewed by Lwaldron on 2021/02/18
Source: Figure 2f
Description:
Abundance in Group 1: increased abundance in Han Healthy at Middle Altitude (MHN)
| NCBI | Quality Control | Links |
|---|---|---|
| Bacteroidota |
Revision editor(s): Manuela
Signature 2
Reviewed Marked as Reviewed by Lwaldron on 2021/02/18
Source: Figure 2f
Description:
Abundance in Group 1: decreased abundance in Han Healthy at Middle Altitude (MHN)
| NCBI | Quality Control | Links |
|---|---|---|
| Bacillota | ||
| Fusobacteriota |
Revision editor(s): Manuela
Retrieved from "https://bugsigdb.org/w/index.php?title=Study_425&oldid=82523"
